Do drug-eluting stents reduce the risk of reintervention compared to bare-metal stents in patients with acute ST-segment elevation myocardial infarction?
This meta-analysis supports the safety and efficacy of drug-eluting stents over bare-metal stents in reducing reintervention risk for acute STEMI patients.
The use of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction is safe and improves clinical outcomes by reducing the risk of reintervention compared with bare-metal stents.
Kastrati et al. (Fri,) studied this question.